Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridium perfringens alpha toxin is a zinc-dependent metalloenzyme and the primary virulence factor produced by C. perfringens, responsible for gas gangrene and myonecrosis in humans and animals. It possesses dual enzymatic activity as a phospholipase C and sphingomyelinase, targeting and hydrolyzing membrane phospholipids such as phosphatidylcholine and sphingomyelin, which leads to cell membrane destruction, lysis, and cytotoxicity. The toxin also induces secondary messenger cascades, stimulates platelet aggregation, increases vascular permeability, and is uniquely associated with hemolytic activity, tissue necrosis, and lethal infections. As a secreted protein of about 370 amino acids, its structure includes an N-terminal catalytic domain and a C-terminal calcium-binding domain that facilitate membrane binding and enzymatic action. Alpha toxin is a key target for vaccine and antitoxin development, but clinical therapy remains mostly supportive, with experimental work on inhibitors and neutralizing antibodies ongoing.
Hydrolyzes phosphatidylcholine and sphingomyelin in cell membranes (via phospholipase C and sphingomyelinase activity), causing membrane disruption and cell death; Induces production of diacylglycerol and ceramide, activating secondary messenger pathways in host cells that cause inflammation and vascular effects
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridium perfringens alpha toxin (CPA).